Polymerase News and Research

RSS

Real-life SARS-CoV-2 Delta variant secondary attack rate on naval ship

A case report appeared recently describing the real-life secondary attack rate of the SARS-CoV-2 Delta variant on a single naval ship.

1 Nov 2021

Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

The current study used the guidelines of the FDA to validate the one-tube SARS-CoV-2 Swift Normalase Amplicon Panel Version 2.0 from Swift Biosciences.

31 Oct 2021

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

A new study investigates the presence of SARS-CoV-2 in tears and eye secretions and describes the ocular symptoms in patients with COVID-19.

31 Oct 2021

The ability of natural flavonoids to inhibit SARS-CoV-2

A recent systematic review discusses naturally occurring flavonoids as a promising antiviral alternative against SARS-CoV-2.

31 Oct 2021

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

Researchers analyze an outbreak of breakthrough infections in a small nursing home in Northerneastern Italy.

28 Oct 2021

Routine surveillance helps detect asymptomatic SARS-CoV-2 vaccine breakthrough infections

In a study published in Annals of Internal Medicine, researchers from Italy systematically monitored 2,397 HCWs who were fully vaccinated with BNT162 at the ASST Settelaghi hospitals in Lombardy, Italy during February 2021. HCWs who worked in 8 wards deemed at “high risk” for infection from attending patients had to undergo mandatory nasopharyngeal swab testing with SARS-CoV-2 polymerase chain reaction every two weeks. HCWs working in 8 “moderate-risk” wards were tested every four weeks.

28 Oct 2021

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

A new study identifies a potent SARS-CoV-2 antiviral, Pheophorbide a (PheoA), which is a compound derived from the plant Marchantia polymorpha L.

27 Oct 2021

COVID-19 and subacute neuropsychiatric symptoms in adolescents

A new paper discusses neurologic symptoms in children with COVID-19.

27 Oct 2021

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Israeli researchers evaluate the antibody response in ICPs to assess antibody-mediated immunity following vaccination with the Pfizer-BioNTech vaccine.

26 Oct 2021

Mapping C. difficile: Advanced ribotyping technology helps researchers keep track of deadly disease

Interview with Seth Walk, Principal Investigator and Associate Professor, Department of Microbiology and Cell Biology, Montana State University

From Promega Corporation 26 Oct 2021

High and increasing SARS-CoV-2 infection prevalence amongst school-aged children in England

The latest round of the REACT-1 study indicates SARS-CoV-2 continues to spread among children.

26 Oct 2021

Study finds FDA-approved drug has potent antiviral activity against SARS-CoV-2 and variants of concern

A new study aimed to examine the antiviral potential of atovaquone against the original SARS-CoV-2 strain and other variants of concern.

25 Oct 2021

Researchers unravel the molecular origins of recombination in RNA viruses

An international consortium, led by Delft University of Technology and the University of North Carolina, has for the first time succeeded in probing the molecular origins of recombination in RNA viruses.

22 Oct 2021

SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months

A new study concludes that at least with predominantly wild-type variants, the risk of reinfection with the virus among unvaccinated people is reduced by 80% or more.

22 Oct 2021

Honeybees can be trained to identify SARS-CoV-2 infected samples, say scientists

In a recent study published on the bioRxiv* pre-print server, researchers from the Netherlands successfully trained honeybees (Apis mellifera) to identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected minks (Neovison vison) using Pavlovian conditioning protocols.

21 Oct 2021

Polymerase News and Research

Real-life SARS-CoV-2 Delta variant secondary attack rate on naval ship

Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel

COVID-19 patients' eyes and tears can be infected with SARS-CoV-2

The ability of natural flavonoids to inhibit SARS-CoV-2

Breakthrough COVID infections in Northeast Italy showing waning vaccine protection

Routine surveillance helps detect asymptomatic SARS-CoV-2 vaccine breakthrough infections

Chlorophyll catabolite pheophorbide A shows potential against SARS-CoV-2

COVID-19 and subacute neuropsychiatric symptoms in adolescents

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Mapping C. difficile: Advanced ribotyping technology helps researchers keep track of deadly disease

High and increasing SARS-CoV-2 infection prevalence amongst school-aged children in England

Study finds FDA-approved drug has potent antiviral activity against SARS-CoV-2 and variants of concern

Researchers unravel the molecular origins of recombination in RNA viruses

SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months

Honeybees can be trained to identify SARS-CoV-2 infected samples, say scientists

Influence of age on innate and adaptive immunity in COVID-19 patients

Children show lower seroconversion rates than adults with mild COVID-19

Biomarker predicts severity of SARS-CoV-2 infection in patients

Two doses of Pfizer-BioNTech vaccine effective in preventing COVID-19 hospitalization among adolescents

Regular testing of SARS-CoV-2 positive vaccinated HCWs may reduce need for long quarantines

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News